CYBO - VanEck Bionic Engineering UCITS ETF (USD) (Acc) (IE0005TF96I9)

The VanEck Bionic Engineering UCITS ETF seeks to replicate as close as possible the price and yield performance of the MVIS Global Bionic Healthcare ESG Index by investing in a portfolio comprised primarily of companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments

The VanEck Bionic Engineering UCITS ETF (USD) (Acc) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in Global. The VanEck fund’s base currency is USD and the share class was registered 02.12.2022 with unique ISIN - IE0005TF96I9. Main exchange is London S.E. (USD) and ticker symbol is CYBO. The total expense ratio is 0.55%. The VanEck Bionic Engineering UCITS ETF (USD) (Acc) pays dividends 0 time(s) per year.